Patents
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/1996
11/28/1996CA2220415A1 Latent transcripts and promoters of cytomegalovirus
11/27/1996EP0744467A2 Multiple antigenic peptide comprising at least two hepatitis C virus-associated peptides
11/27/1996EP0743983A1 Mammalian thymokine genes
11/27/1996EP0743956A1 Pretargeting methods and compounds
11/27/1996EP0743870A1 Preparation and application of artificial anti-idiotypic imprints
11/27/1996EP0743856A1 Antigen-based heteropolymers and method for treating autoimmune diseases using the same
11/27/1996CN1136778A Sperm antigen corresponding to sperm zone binding protein autoantigenic epitope
11/27/1996CA2177328A1 Anti-idiotypic antibodies which induce an immune response against epidermal growth factor receptor
11/26/1996US5578715 Methods, kits, and probes for diagnosing HIV-2
11/26/1996US5578714 DNA encoding Duffy 9pd protein
11/26/1996US5578708 Derived from bones of mammals including mice and humans; diagnosis and therapy for bone metabolic diseases
11/26/1996US5578703 Dimer proteins which bind to transforming growth factor
11/26/1996US5578496 Detection of autoantibodies associated with the disease myasthenia gravis
11/26/1996US5578473 Recombinant negative strand RNA virus
11/26/1996US5578453 Cloning and expression of toxoplasma antigens and use of recombinant antigens
11/26/1996US5578448 Polymerase chain reaction
11/26/1996US5578323 Proteinoid carriers and methods for preparation and use thereof
11/26/1996US5578309 For the treatment of candidiasis
11/26/1996US5578308 Glutaraldehyde and formalin detoxified bordetella toxin vaccine
11/26/1996US5578303 Vaccines, t-cells with specificity for heat shock protein 65
11/26/1996US5578289 Administering antibody-enzyme conjugate
11/26/1996US5578287 Three-step pretargeting methods using improved biotin-active agent
11/21/1996WO1996036713A2 Eck receptor ligands
11/21/1996WO1996036711A2 Islet-specific homeoprotein and transcriptional regulator of insulin gene expression
11/21/1996WO1996036709A1 Transforming growth factor alpha hii
11/21/1996WO1996036705A1 Viral vectors
11/21/1996WO1996036699A1 Non-pathogenic strains of hiv-1 and methods for detecting same
11/21/1996WO1996036698A1 Mch2, AN APOPTOTIC CYSTEINE PROTEASE, AND COMPOSITIONS FOR MAKING AND METHODS OF USING THE SAME
11/21/1996WO1996036366A1 Gene therapy for effector cell regulation
11/21/1996WO1996036359A1 Induction of immunological tolerance by the use of non-depleting anti-cd4 antibodies
11/21/1996WO1996036358A1 Compositions and methods for inhibiting xenograft rejection
11/21/1996WO1996036357A1 Carbohydrate-mediated coupling of peptides to immunoglobulins
11/21/1996WO1996036356A1 Viral agent associated with mystery swine disease
11/21/1996WO1996036355A1 Leptospira membrane proteins
11/21/1996WO1996036354A2 Anticancer vaccine comprising il6/il6 receptor transfected cells
11/21/1996WO1996036317A1 Production scale method of forming microparticles
11/21/1996WO1996033414A3 Compounds and methods for diagnosis of leishmaniasis
11/21/1996WO1996029605A3 Compounds and methods for the dectection of t. cruzi infection
11/21/1996DE19530272C1 Monoclonal antibody specific for cell-surface glyco-protein MGC-24
11/21/1996CA2227326A1 Carbohydrate-mediated coupling of peptides to immunoglobulins
11/21/1996CA2221350A1 Induction of immunological tolerance by the use of non-depleting anti-cd4 antibodies
11/21/1996CA2221305A1 Gene therapy for effector cell regulation
11/21/1996CA2221234A1 Compositions and methods for inhibiting xenograft rejection
11/21/1996CA2220674A1 Leptospira membrane proteins
11/20/1996EP0742903A1 Piperidine analogs and conjugates of procainamide and napa
11/20/1996EP0742834A1 Method of preparing a viral vector by homologous intermolecular recombination
11/20/1996EP0742830A1 Fusion proteins that include antibody and nonantibody portions
11/20/1996EP0742829A1 Expression of heterologous proteins in attenuated bacteria using the htra-promoters
11/20/1996EP0742823A1 T-cell antigens, and their use in diagnosis and treatment of t-cell mediated conditions
11/20/1996EP0742795A1 Immuno-stimulatory monoclonal antibodies
11/20/1996EP0742721A1 Methods of prolonged suppression of humoral immunity
11/20/1996EP0550544B1 Antigen-antibody conjugates
11/20/1996EP0542895B1 Cross-reactive influenza a immunization
11/20/1996EP0517895B1 Chimeric chains for receptor-associated signal transduction pathways
11/20/1996EP0174990B2 Immunofixation electrophoresis process
11/20/1996CN1136328A Analog of haemophilus HIN47 with reduced protease activity
11/20/1996CN1136280A Anti-aids secretory recombinant BCG vaccine
11/19/1996US5576421 Recombinant chimeric HIV-1 Gag-Env fusion proteins
11/19/1996US5576175 Complex suitable for carrying out a method of purifying pre-S hepatitis B surface antigen
11/19/1996US5576003 Ornithobacterium rhinotracheale vaccine and method of immunization
11/19/1996US5576002 Meningococcal polysaccharide conjugate vaccine
11/19/1996US5576000 Envelope protein of hiv with sequences
11/19/1996CA2096315C Human rotaviruses, vaccines and methods
11/14/1996WO1996035787A1 Nucleic acids for treating obesity
11/14/1996WO1996035719A1 Transeptithelial transport of molecular species
11/14/1996WO1996035716A1 Fibroblast growth factor homologous factor-2 and methods of use
11/14/1996WO1996035710A1 Preparation of immunoglobulin
11/14/1996WO1996035708A1 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use
11/14/1996WO1996035451A1 Novel toxin complex
11/14/1996WO1996035450A1 Diagnostic tests for a new spirochete, borrelia lonestari
11/14/1996WO1996035438A1 Oncogene fusion protein peptide vaccines
11/14/1996WO1996035416A1 Localized use of nitric oxideadducts to prevent internal tissue damage
11/14/1996WO1996031186A3 Product and method for preventing respiratory virus infection
11/14/1996CA2220917A1 Fibroblast growth factor homologous factor-2 and methods of use
11/14/1996CA2220893A1 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use
11/14/1996CA2218529A1 Nucleic acids for treating obesity
11/13/1996EP0742229A2 Induction of protection against viral infection
11/13/1996EP0742015A1 Prodrugs for beta-lactamase and uses thereof
11/13/1996EP0742014A1 MHC-peptide labelled conjugates
11/13/1996EP0741869A1 Specific binding substances for antibodies and their use for immunoassays or vaccines
11/13/1996EP0741792A1 Herpesvirus pre-(viral dna replication) enveloped
11/13/1996EP0741789A1 Process for the production of a heterologous protein from a methylotrophic yeast
11/13/1996EP0741788A1 Inducing tolerance with tolerogenic fusion proteins
11/13/1996EP0741787A1 Mammalian expression systems for hepatitis c virus envelope genes
11/13/1996EP0741786A1 Vaccine compositions comprising live bacterial vectors for protection against yersinia pestis injection
11/13/1996EP0741784A1 Ligand (act-4-l) to a receptor on the surface of activated cd4?+ t-cells
11/13/1996EP0741748A1 Monoclonal antibodies specific to vegf receptors and uses thereof
11/13/1996EP0741745A1 Hepatitis b vaccine
11/13/1996EP0741744A1 Immunogens against gonadotropin releasing hormone
11/13/1996EP0741580A1 Controlled release of pharmaceutically active substances for immunotherapy
11/13/1996EP0741578A1 Human growth hormone
11/13/1996EP0741573A1 Use of diesters of muramyl peptides in oral form as immunostimulating agents
11/13/1996EP0496787B1 Novel infectious bursal disease virus
11/13/1996EP0480014B1 SYNTHETIC POLY-Ig RECEPTOR, RECEPTOR-ANTIBODY COMPLEXES, PRODUCTION AND USE THEREOF
11/13/1996EP0474868B1 Method of producing core structure of retro virus and particle produced thereby
11/13/1996EP0474691B1 Monoclonal antibodies for inducing tolerance
11/13/1996EP0373168B1 Polypeptide useful in diagnosis of coccidia infection and recombinant-dna methods for manufacturing same
11/13/1996CN1135771A DNA sequence coding for a BMP receptor
11/13/1996CN1135759A Membrane protein polypeptide having functions of supporting pre-B cell growth and gene thereof
11/13/1996CN1135718A Method and products for controlling immune responses in mammals